Neoadjuvant chemoradiotherapy plus PD-1 blockade for high or very high-risk locally advanced rectal cancer

被引：0
|
作者：
Liu, X. [1 ]
He, L. [2 ]
Tong, W. [2 ]
Li, S. [2 ]
Wang, Z. [1 ]
Gu, M. [1 ]
Li, Y. [1 ]
Liu, Z. [1 ]
Chang, P. [1 ]
Wang, Q. [2 ]
机构：
[1] First Hosp Jilin Univ, Dept Radiat Oncol & Therapy, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Dept Gastrocolorectal Surg, Gen Surg Ctr, Changchun, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1016/j.annonc.2024.05.259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
252P
引用
收藏
页码：S108 / S108
页数：1
相关论文
共 50 条
  • [41] PKUCH 04 trial: Total neoadjuvant chemoradiation combined with neoadjuvant PD-1 blockade for pMMR/MSS locally advanced middle to low rectal cancer.
    Wu, Aiwen
    Li, Yingjie
    Ji, Dengbo
    Zhang, Li
    Zhang, Xiaoyan
    Cai, Yong
    Zhang, Yangzi
    Yao, Yunfeng
    Wang, Lin
    Leng, Jiahua
    Zhan, Tiancheng
    Sun, Ying-Shi
    Li, Zhongwu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer
    Hussain, M
    Smith, DC
    El-Rayes, BF
    Du, W
    Vaishampayan, U
    Fontana, J
    Sakr, W
    Wood, D
    UROLOGY, 2003, 61 (04) : 774 - 780
  • [43] Effective PD-1 receptor inhibition in locally advanced rectal cancer
    不详
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2022, 60 (11): : 1601 - 1601
  • [44] Total neoadjuvant treatment of locally advanced rectal cancer with high risk factors in Slovenia
    Tuta, Mojca
    Boc, Nina
    Brecelj, Erik
    Omejc, Mirko
    Anderluh, Franc
    Ermenc, Ajra Secerov
    Peressutti, Ana Jeromen
    Oblak, Irena
    Krebs, Bojan
    Velenik, Vaneja
    RADIOLOGY AND ONCOLOGY, 2019, 53 (04) : 465 - 472
  • [45] Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal cancer
    Cheng, X.
    Chen, Y.
    Wu, X.
    Hao, D.
    Zhang, Y.
    Li, X.
    ANNALS OF ONCOLOGY, 2016, 27
  • [46] The Neoadjuvant Administration of PD-1 Inhibitor plus Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous-Cell Carcinoma
    Chen, Yong
    Zhu, Shuangmei
    Lan, Xiang
    Hu, Tianzhen
    Ma, Lele
    Ye, Hong
    Wang, Baoqiang
    He, Xiao
    Wang, Hanying
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2024, 2024
  • [47] HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study
    Chang, Xu
    Li, Xinge
    Sun, Peng
    Li, Zhenfeng
    Sun, Pengfei
    Ning, Shangkun
    BMC CANCER, 2024, 24 (01)
  • [48] Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
    Qian, Ting
    Liu, Delin
    Cao, Guochun
    Chen, Zhipeng
    Zhang, Qin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [49] Neoadjuvant chemoradiotherapy for locally advanced rectal cancer with peritumoral abscesses and fistulas
    Gordeyev, Sergey
    Ivanov, Valerii
    Fedianin, Mikhail
    Chernikh, Marina
    Kozlov, Nikolay
    Petrov, Leonid
    Erygin, Dmitriy
    Gridasov, Ivan
    Kaushanskiy, Valery
    Feoktistov, Dmitry
    Mamedli, Zaman
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (02) : 201 - 208
  • [50] Surgical and short-term oncological safety of total neoadjuvant therapy in high-risk locally advanced rectal cancer
    Ng, Yvonne Y.
    Seow-En, Isaac
    Chok, Aik Yong
    Lee, Terence S.
    Palanisamy, Prasad
    Tan, Emile K.
    ANZ JOURNAL OF SURGERY, 2024, 94 (1-2) : 175 - 180
12345